Correct on both counts. BMY's CEO was heavily criticized for not doing the due diligence on Erbitux prior to signing the huge deal with IMCL a few months before the RTF.
The FDA has three options at the 45-60 day deadline for acceptance of the BLA:
Accept with Priority Review Accept with Standard Review RTF Notice (no acceptance)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.